Stock ownership · SEC 13F · Q4 2025

GSK PLC ADR F

A breakdown of GSK PLC ADR F's institutional base (CUSIP 37733W204): the holders, the concentration among them, and what changed last quarter.

$4.2M
Reported value
8
Institutions
100%
Top-5 share

The verdict

According to SEC Form 13F-HR filings in this corpus, GSK PLC ADR F ranks #590 of 775 tracked securities by reported institutional value (largest first), matching the /stocks listing among names with ≥5 reporting holders. 8 institutions report $4.2M as of Q4 2025, with ownership held overwhelmingly by a small core of institutions.

8
institutions hold it
$4.2M
reported 13F value
100%
held by top 5
#590
of 775 by value

Based on long positions reported to the SEC as of Q4 2025; 13F omits shorts, options and non-US holdings.

According to SEC Form 13F-HR filings in this corpus, GSK PLC ADR F ranks #590 of 775 tracked securities by reported institutional value (largest first), matching the /stocks listing among names with ≥5 reporting holders.

How 13F ownership is computed · All tracked stocks · Concentration rankings

SEC Form 13F-HR ownership desk

CUSIP 37733W204 · Q4 2025 $4M reported

VALUE-LIGHT · HOLDERS-FOCUS · CONC-DOM · PHOTO-FINISH · ACTIVITY-MID · BOOK-FULL

  • VALUE-LIGHT #590/775
  • HOLDERS-FOCUS 8 filers
  • CONC-DOM 100% top-5
  • PHOTO-FINISH PRINCIPAL FINL GROUP
  • ACTIVITY-MID 5 new
  • BOOK-FULL 8Q history

Photo-finish peer on reported value: PRINCIPAL FINL GROUP INC

Read with: Ownership concentration guide - GSK PLC ADR F's top-five holders account for 100% of reported value — read concentration before treating any single filer as a signal.

Reported-value neighbourhood · GSK PLC ADR F

Nearest tracked securities by aggregate 13F reported value, not a full corpus reprint.

VANECK GOLD MINERS ETF · near$4MGSK ADR F · this stock$4MPRINCIPAL FINL GROUP · near$4MCBOE GLOBAL MKTS · near$4MBANCO BILBAO VIZCAYA… · near$4M
Aggregate reported institutional value ($)
Largest institutional holders of GSK PLC ADR F
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Top 6 reported holders by value · Q4 2025

Institutional ownership over time

The number of institutions reporting a GSK PLC ADR F position has risen from 7 to 8 over the last 8 quarters of 13F filings.

05101520 Q1'24Q2'24Q3'24Q4'24Q1'25Q2'25Q3'25Q4'25 8
Distinct 13F filers holding GSK PLC ADR F, by quarter

Top Institutional Holders

# Institution Shares Value Share of reported
1 DGS Capital Management, LLC 39,934 $2.0M 46.9%
2 Anchor Investment Management, LLC 35,390 $1.7M 41.5%
3 CHELSEA COUNSEL CO 9,360 $463K 11.1%
4 MidFirst Bank 160 $8K 0.2%
5 Bell Investment Advisors, Inc 148 $7K 0.2%
6 TD Capital Management LLC 80 $4K 0.1%
7 Strategic Investment Solutions, Inc. /IL 44 $2K 0.1%
8 SG Trading Solutions, LLC 11,567 $567 0.0%

Investment Discretion

SEC Form 13F requires each institutional filer to report whether it exercises sole or shared discretion over a position. Among GSK PLC ADR F's reported holders for Q4 2025, by reported value:

Sole discretion (SOLE)
100.0%

Latest Quarter Activity · Q4 2025

Frequently Asked Questions

How many institutions hold GSK PLC ADR F?
GSK PLC ADR F is held by 8 institutional investors per the latest SEC Form 13F filings as of Q4 2025.
Where does GSK PLC ADR F sit among tracked securities?
According to SEC Form 13F-HR filings in this corpus, GSK PLC ADR F ranks #590 of 775 tracked securities by reported institutional value (largest first), matching the /stocks listing among names with ≥5 reporting holders. The ordinal is recomputed live among securities with ≥5 reporting holders. See /methodology/#corpus-placement.
What is the total institutional value of GSK PLC ADR F?
Institutions report $4.2M of GSK PLC ADR F as of Q4 2025.
How concentrated is ownership of GSK PLC ADR F?
The top five institutional holders account for 100% of the reported institutional value in GSK PLC ADR F, making ownership held overwhelmingly by a small core of institutions.
Who is the largest institutional holder of GSK PLC ADR F?
DGS Capital Management, LLC is the largest reported holder of GSK PLC ADR F with $2.0M across 39,934 shares as of Q4 2025.

Nationwide stocks with similar institutional value or holder count

Two 13F-derived peer sets for GSK PLC ADR F: nearest aggregate reported value and nearest institutional holder count, not catalog browse links.

Similar reported value

Nearest stocks by aggregate 13F reported value ($4.2M here).

Similar holder count

Nearest stocks by number of disclosing 13F holders (8 here).

Source: U.S. Securities and Exchange Commission (SEC) - EDGAR Form 13F-HR institutional holdings filings · Q4 2025 13F-HR discloses long US-listed equity positions of managers with $100M+ qualifying assets, filed within 45 days of period end. Short positions and most derivatives are not disclosed.

PlainFundData is rendered directly from SEC EDGAR Form 13F-HR institutional holdings filings, no number is typed in by an editor. Holder lists, concentration, and reported value on this page are aggregated live from those 13F-HR extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-16.